Meeting Format and Agenda
Prior to the event, RTP will video record several community-based medical oncologists presenting challenging non-small cell lung cancer (NSCLC) cases from their practices. To begin each meeting module, one or more of these recorded cases will be presented. Dr Love will then ask the faculty to provide their perspectives in an effort to demonstrate the optimal approach to patient care. After the case presentation(s) for each module, one of the faculty will deliver a short presentation on emerging research and ongoing trials related to a particular area of NSCLC management. Moderated panel discussion will follow to provide additional viewpoints on the information presented.
MODULE 1: Long-Term Management of NSCLC in Patients with an Activating EGFR Mutation — Dr Oxnard
MODULE 2: Recent Treatment Advances for Patients with ALK/ROS1- and BRAF-Positive NSCLC; Other Targets with the Potential to Affect Treatment Decision-Making — Dr Shaw
MODULE 3: Optimal Integration of Immune Checkpoint Inhibition into Clinical Decision-Making for Patients with Locally Advanced NSCLC — Dr Reck
MODULE 4: Current Role of Immune Checkpoint Inhibitors in Combination with Chemotherapy and/or Anti-angiogenic Agents in the Treatment of Metastatic Disease — Dr Langer
MODULE 5: Potential Role of Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies in Combination; Future Directions for Clinical Research — Dr Hellmann
Target Audience:
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of non-small cell lung cancer (NSCLC).
Learning Objectives and Goals:
At the conclusion of this activity, participants should be able to:
CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.
Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement:
Research To Practice designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.
Supporters:
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Foundation Medicine, Genentech BioOncology, Merck and Takeda Oncology.
Hilton Chicago
720 South Michigan Avenue
Chicago, IL 60605
Hotel Phone: (312) 922-4400
Meeting Room:
Grand Ballroom (Level 2)
Directions:
The Hilton Chicago hotel is located just 5 minutes (2.5 miles) north of the McCormick Place convention center.
Thank you for your interest in our educational program. At this time, online preregistration is closed. However, seats are still available for the conference. Onsite registration will be open starting at 6:30 PM (Central Time) on Friday, June 1st. If you are interested in attending, please visit our registration desk in the Grand Ballroom foyer located on the second level of the Hilton Chicago (720 Michigan Avenue, Chicago, IL).
Please note, onsite registrant seating will be prioritized for healthcare professionals directly involved in the treatment of patients. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com or call (800) 233-6153.